Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-EN Version v18-EN
Language English English
Date Updated 2019-07-30 2019-07-29
Drug Identification Number 02210347 02210347
Brand name MYLAN-VERAPAMIL SR MYLAN-VERAPAMIL SR
Common or Proper name VERAPAMIL SR VERAPAMIL SR
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE
Strength(s) 120MG 120MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BT 100 BT
ATC code C08DA C08DA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-05-01 2019-05-01
Actual start date 2019-04-16 2019-04-16
Estimated end date 2019-07-26 2019-07-26
Actual end date 2019-07-29 2019-07-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments